High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$268K
$268,070
Total Sells (Filtered)
$829K
$829,379
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ARVN |
ARVINAS, INC.
|
Director
Discretionary BuyΔOwn +26.3%
|
2026-03-06 | $268,070 | P | Form 4 |
| ARVN |
ARVINAS, INC.
|
Director
Sell to Cover
|
2026-02-27 | $466,154x3 | S | Form 4 |
|
ARVN
S
ARVINAS, INC.
Cacace Angela M
• Officer • Chief Scientific Officer
Sell to Cover
2026-02-23
$43,885x2
|
||||||
| ARVN |
ARVINAS, INC.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-02-23 | $43,885x2 | S | Form 4 |
|
ARVN
S
ARVINAS, INC.
Loomis David K
• Officer • Chief Accounting Officer
Sell to Cover
2026-02-23
$13,473
|
||||||
| ARVN |
ARVINAS, INC.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2026-02-23 | $13,473 | S | Form 4 |
| ARVN |
ARVINAS, INC.
|
CEO
Sell to Cover
|
2026-02-23 | $58,198x2 | S | Form 4 |
|
ARVN
S
ARVINAS, INC.
Berkowitz Noah
• Officer • Chief Medical Officer
Sell to Cover
2026-02-13
$67,595
|
||||||
| ARVN |
ARVINAS, INC.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-02-13 | $67,595 | S | Form 4 |
|
ARVN
S
ARVINAS, INC.
Cacace Angela M
• Officer • Chief Scientific Officer
Sell to Cover
2026-02-13
$54,599
|
||||||
| ARVN |
ARVINAS, INC.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-02-13 | $54,599 | S | Form 4 |
|
ARVN
S
ARVINAS, INC.
Loomis David K
• Officer • Chief Accounting Officer
Sell to Cover
2026-02-13
$12,080
|
||||||
| ARVN |
ARVINAS, INC.
|
Officer • Chief Accounting Officer
Sell to Cover
|
2026-02-13 | $12,080 | S | Form 4 |
| ARVN |
ARVINAS, INC.
|
CFO
Sell to Cover
|
2026-02-13 | $61,043 | S | Form 4 |
| ARVN |
ARVINAS, INC.
|
CEO
Sell to Cover
|
2026-02-13 | $52,352 | S | Form 4 |